Tiersten, A. D., Moon, J., Smith, H. O., Wilczynski, S. P., Robinson, 3., Markman, M., & Alberts, D. S. (2010). Chemotherapy Resistance as a Predictor of Progression-Free Survival in Ovarian Cancer Patients Treated with Neoadjuvant Chemotherapy and Surgical Cytoreduction Followed by Intraperitoneal Chemotherapy: A Southwest Oncology Group Study. S. Karger AG.
Citação norma ChicagoTiersten, Amy D., James Moon, Harriet O. Smith, Sharon P. Wilczynski, 3rd Robinson, Maurie Markman, and David S. Alberts. Chemotherapy Resistance As a Predictor of Progression-Free Survival in Ovarian Cancer Patients Treated With Neoadjuvant Chemotherapy and Surgical Cytoreduction Followed By Intraperitoneal Chemotherapy: A Southwest Oncology Group Study. S. Karger AG, 2010.
Citação norma MLATiersten, Amy D., et al. Chemotherapy Resistance As a Predictor of Progression-Free Survival in Ovarian Cancer Patients Treated With Neoadjuvant Chemotherapy and Surgical Cytoreduction Followed By Intraperitoneal Chemotherapy: A Southwest Oncology Group Study. S. Karger AG, 2010.